Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to 'denatured' aldolase A in the osteoblast-like cell line, MG- 63

Annals of the Rheumatic Diseases

Volumn 58, Issue 3, 1999, Pages 169-174

  Ukaji, Fumio ^a,b   Kitajima, Isao ^a,e   Kubo, Toshikazu ^c   Shimizu, Choji ^c   Nakajima, Toshihiro ^d   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b TOKUYAMA CORPORATION   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FRUCTOSE BISPHOSPHATE ALDOLASE;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; BONE EROSION; ENZYME DENATURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOLYSIS; HUMAN; HUMAN CELL; INFLAMMATORY CELL; OSTEOBLAST; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

EID: 0032960240     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.3.169     Document Type: Article

References (21)

1. 1 Cush JJ, Lipsky PE. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 1988;13:151-60.
2. 2 Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
3. 3 Simon M, Girbal E, Sebbag M, Gomes-Daudrix V, Vincent C, Salama G, et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies", autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993;92:1387-93.
4. 4 Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Durieux JJ, et al. The antiperinuclear factor and so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95: 2672-9.
5. 5 Steiner G, Hartmuth K, Skriner K, Maurer-Fogy I, Sinski A, Thalmann E, et al. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest 1992;90:1061-6.
6. 6 Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS. Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. Br J Rheumatol 1993;32:199-203.
7. 7 Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, et al. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J Clin Invest 1997;100:127-35.
8. 8 Mimori T, Suganuma K, Tanami Y, Nojima T, Matsumura M, Fujii T, et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA 1995;92:7267-71.
9. 9 Despres N, Talbot G, Plouffe B, Boire G, Menard HA. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest 1995;95:1891-6.
10. 10 Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
11. 11 Stuart JM, Huffstutter EH, Townes AS, Kang AH. Incidence and specificity of antibodies to type I, II, III, IV, and V collagen in rheumatoid arithritis and other rheumatic disease as measured by 125I-radioimmunoassay. Arthritis Rheum 1983;26:832-40.
12. 12 Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu M, et al. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 1990;33: 1493-500.
13. 13 Sakawa A, Yutani Y, Inui K, Shimazu A, Yamano Y, Kinoshita A, et al. Specific serum antibodies against membranous proteins of human immortal chondrocytic cell line (HCS-2/8) in rheumatoid arthritis and their relationship to the natural history of this disease. J Bone Miner Metab 1996;14:146-52.
14. 14 Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. 15 Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by the standard reference films. Acta Radiol Diagn 1977;18:481-91.
16. 16 Steinbrocker O, Traeger CH, Battermann RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
17. 17 Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
18. 18 Hewick RM, Hunkapiller MW, Hood LE, Dreyer WJ. A gas-liquid solid phase peptide and protein sequenator, J Biol Chem 1981;256:7990-7.
19. 19 O'Hara BP, Pyle J, McCarthy D, Archer JR. Binding of monometric and aggregated immunoglobulin to enzymes. A source of artefact in antibody assays. J Immunol Methods 1989;116:175-9.
20. 20 Itoh Y, Reichlin, M. Autoantibodies to the Ro/SSA antigens are conformation dependent. I: Anti-60kD antibodies are mainly directed to the native protein; anti-52kD antibodies are mainly directed the denatured protein. Autoimmunity 1992;14:57-65.
21. 21 Tsuzaka K, Fujii T, Akizuki M, Mimori T, Tojo T, Fujii H, et al. Clinical significance of antibodies to native or denatured 60-kd or 52-kd Ro/SS-A proteins in Sjögren's syndrome. Arthritis Rheum 1994;37:88-92.